The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Toth Christopher A. since 2019.
This trader's CIK number is 1753950.
At the time of last reporting, Toth Christopher A. was the SVP and Pres. Oncology Systems of Varian Medical Systems Inc. (stock ticker symbol VAR).
Also see all insider trading activities at Varian Medical Systems Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | VAR | 0 | $0 | 0 | $0 | 2,376 | $0 |
| 2020 | VAR | 0 | $0 | 3,222 | $410,739 | 51,268 | $4,638,117 |
| 2019 | VAR | 0 | $0 | 9,196 | $1,267,295 | 10,969 | $661,317 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-16 | VAR | Option Ex | 2,376 | .00 | 0 |
| 2020-12-01 | VAR | Option Ex | 47,234 | 94.38 | 4,457,944 |
| 2020-04-13 | VAR | Sale | 1,625 | 110.26 | 179,174 |
| 2020-02-18 | VAR | Option Ex | 2,437 | .00 | 0 |
| 2020-01-03 | VAR | Sale | 1,597 | 145.00 | 231,565 |
| 2020-01-03 | VAR | Option Ex | 1,597 | 112.82 | 180,173 |
| 2019-12-06 | VAR | Sale | 564 | 139.09 | 78,445 |
| 2019-04-01 | VAR | Option Ex | 1,400 | 112.82 | 157,948 |
| 2019-04-01 | VAR | Sale | 1,400 | 142.50 | 199,500 |
| 2019-03-21 | VAR | Option Ex | 1,211 | 80.40 | 97,364 |
| 2019-03-22 | VAR | Option Ex | 1,400 | 112.82 | 157,948 |
| 2019-03-21 | VAR | Sale | 1,211 | 137.50 | 166,512 |
| 2019-03-22 | VAR | Sale | 1,400 | 140.00 | 196,000 |
| 2019-03-18 | VAR | Option Ex | 3,498 | 70.91 | 248,057 |
| 2019-03-18 | VAR | Sale | 4,621 | 135.65 | 626,838 |
| 2019-02-15 | VAR | Option Ex | 3,460 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Toth Christopher A. (SVP and Pres. Oncology Systems of Varian Medical Systems Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.